Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma

Rheumatology (Oxford). 2021 Feb 1;60(2):e59-e60. doi: 10.1093/rheumatology/keaa572.

Authors

Marco Caminati¹, Matteo Maule², Francesca Nalin², Gianenrico Senna¹, Claudio Lunardi¹

Affiliations

¹ Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy.
² Department of Medicine, School of specialization in Allergy and Clinical Immunology, University of Verona, Verona, Italy.

PMID: 32940680
DOI: 10.1093/rheumatology/keaa572

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Asthma / drug therapy*
Churg-Strauss Syndrome / chemically induced*
Churg-Strauss Syndrome / diagnosis
Eosinophils / pathology*
Female
Granulomatosis with Polyangiitis / chemically induced*
Granulomatosis with Polyangiitis / diagnosis
Humans
Interleukin-5 / antagonists & inhibitors*
Middle Aged
Severity of Illness Index

Substances

Antibodies, Monoclonal, Humanized
Interleukin-5
mepolizumab